NBIR Device Tracking
NBIR Device Tracking is a medical utility for plastic surgeons to capture and submit breast implant data to the National Breast Implant Registry on iOS and Android.
The App DNA
What makes this app unique?
The application removes the administrative burden of manual data entry for federally-mandated post-market surveillance requirements.
For Plastic surgeons and clinical staff responsible for breast implant device tracking and regulatory compliance.
What does it look like?
Key features
Scans patient demographic forms and breast implant device barcodes using optical character recognition.
Packages captured data into secure case report forms for submission to the National Breast Implant Registry.
Consolidates device tracking requirements for Allergan, Mentor, and Sientra into a single workflow.
How much does it cost?
The application is provided as a free utility to facilitate mandatory federal data reporting for the Plastic Surgery Foundation.
Velocity
Maintenance developmentperformanceopaqueShow more...
NBIR Device Tracking has been inactive for 249 days, with the latest release occurring in mid-January 2026. Development is currently limited to minor maintenance, as the most recent updates provided only generic stability and performance fixes. There is no evidence of new features or live operations, indicating a long-term maintenance cycle. The lack of updates over the last eight months suggests the product is currently in a stable, legacy state.
Who built it?
American Society of Plastic Surgeons
4 apps tracked · Medical
User Sentiment
What do users think recently?
Review voice lately leans upset.
How are ratings & reviews evolving?
What users say, by theme
- Inaccurate scanning of medical implant barcodes prevents clinicians from completing required patient tracking documentation
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisUnlock 2 more frustration themes, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for NBIR Device Tracking
How's the Medical market?
NBIR Device Tracking occupies a niche regulatory compliance space with a 3.27-star rating across 11 total ratings. The lack of updates for over 240 days signals a maintenance-only posture that limits its ability to address active clinical workflow complaints.
The rivals identified
The Analyst's Read
Key takeaways for NBIR Device Tracking
Where is it heading?
The regulatory compliance market for medical registries requires high-reliability tools to minimize clinical friction. NBIR Device Tracking's current maintenance-only posture leaves critical scanning errors unaddressed, which threatens the registry's data collection goals and risks physician abandonment of the workflow.
- Stalled development cadence (no features in eight months) prevents resolution of critical scanning errors, which compounds the administrative burden on clinical staff.
- Persistent barcode scanning inaccuracies prevent clinicians from completing mandatory patient tracking, which risks the overall data integrity of the National Breast Implant Registry.
The SWOT
- OCR scanning automates data entry for federally-mandated registry submissions
- Multi-manufacturer support consolidates Allergan, Mentor, and Sientra tracking workflows
- Scanner reliability improvements would reduce administrative friction for clinical users
- Enhanced support documentation could resolve patient data synchronization errors
Next best moves
Rebuild OCR scanning logic because barcode identification failure is the top clinical complaint → increase successful patient registration rate.
+ 1 more prioritized moveThe counter-intuitive read
The lack of updates is not just technical neglect…
Read the full takeBottom line
Improving scanner reliability and technical support responsiveness would resolve the primary friction points preventing clinicians from meeting mandatory registry requirements, thereby securing the data integrity of the National Breast Implant Registry.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
- [2] Play Store
Report last updated